BPC 157 has been shown to inhibit inflammation by blocking the production of proinflammatory mediators such as prostaglandins and leukotrienes
Clinical Trials 17 (1), 112
Peptides, or small protein fragments, are often too unstable to use as drugs, but in this study, the researchers also developed a way to stabilize the molecules and help them get into target cells
Our pharmacist will review your medical history, discuss your symptoms, and confirm your eligibility for the injections
Ending On A Promising Note Yes, a large share of all BPC-157 research comes from a single research team, and independent labs still need to confirm the findings
Excipients in formulations may occasionally trigger sensitivity reactions in some individuals